Dating App Company $BMBL Plummets 86%, Biotech Firms $AKRO and $BBIO Raise $320M and $250M in Offerings

Dating app company $BMBL is experiencing an 86% drop in stock value but still maintains a $2 billion market capitalization despite not being profitable. Biotech firm $AKRO successfully priced a $320 million offering with 11 million shares at $29 each, exceeding the initial $300 million target. Another biotech company, $BBIO, completed a $250 million offering with 8.6 million shares at $29 each, contributing to a total fundraising of $1 billion over the past two months without compromising core assets or diluting shareholders, although the stock has declined by almost 30% recently.